SCHEMBL756080

SCHEMBL756080

CC(C)(C)P(C)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8332288 0.80
SCHEMBL335957 0.78
SCHEMBL14178229 0.77
SCHEMBL14178230 0.77
SCHEMBL18670139 0.77
SCHEMBL1362160 0.75 LMNA (0.47)
Hydrochloric Acid SCHEMBL9775705 0.75 LMNA (0.56)
SCHEMBL21382633 0.75
SCHEMBL14029134 0.74 LMNA (0.47)
Phosphoric Acid SCHEMBL28215683 0.73 LMNA (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2145893-B1 Salts of diorganyl phosphinic acids, method for their manufacture and their application CLARIANT PRODUKTE DEUTSCHLAND (DE) 2012-07-11 EP claimed
EP-2141169-B1 Salts of diorganyl phosphinic acids, method for their manufacture and their application CLARIANT PRODUKTE DEUTSCHLAND (DE) 2012-03-21 EP claimed
EP-1607400-B1 Salts of dialkylphosphinic acids, process for their preparation and their use CLARIANT PRODUKTE DEUTSCHLAND (DE) 2009-12-02 EP claimed
US-20240238323-A1 MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES EMORY UNIVERSITY 2024-07-18 US disclosed
US-11917904-B2 Perovskite solar cell CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2024-02-27 US disclosed
CN-117441219-A Electrolyte for electrolytic capacitor, electrolytic capacitor using the same, and hybrid electrolytic capacitor 三洋化成工业株式会社 2024-01-23 CN disclosed
US-11872236-B2 Pharmacological agents for treating ocular diseases CALASIA PHARMACEUTICALS, INC. (US) 2024-01-16 US disclosed
US-11840521-B2 Modulators of Mas-related G-protein receptor X4 and related products and methods ESCIENT PHARMACEUTICALS, INC. (US) 2023-12-12 US disclosed
US-20230354696-A1 PEROVSKITE SOLAR CELL CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2023-11-02 US disclosed
US-11773077-B2 Compounds containing carbon-carbon linker as GPR120 agonists Piramal Enterprises Limited (IN) 2023-10-03 US disclosed
US-11753638-B2 Conjugated oligonucleotides UNIVERSITY OF MASSACHUSETTS (US) 2023-09-12 US disclosed
US-20140220049-A1 MICRORNA INHIBITION FOR THE TREATMENT OF INFLAMMATION AND MYELOPROLIFERATIVE DISORDERS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-08-07 US disclosed
US-20140154675-A1 Flash and Glow 1,2-Dioxetanes Life Technologies Corporation (US) 2014-06-05 US disclosed
US-20130289027-A1 Isoquinoline Compounds And Methods For Treating HIV VIIV HEALTHCARE UK LIMITED (GB) 2013-10-31 US disclosed
US-20130196325-A1 In Situ Chemiluminescent Substrates and Assays Life Technologies Corporation (US) 2013-08-01 US disclosed
US-20130018049-A1 Azaindole Compounds and Methods for Treating HIV GLAXOSMITHKLINE LLC (US) 2013-01-17 US disclosed
US-8173680-B2 Cannabinoid receptor modulators 7TM PHARMA A/S (DK) 2012-05-08 US disclosed
US-8017763-B2 Chemically modified oligonucleotides ALNYLAM PHARMACEUTICALS, INC. (US) 2011-09-13 US disclosed
US-20100292273-A1 Cannabinoid Receptor Modulators 7TM PHARMA A/S (DK) 2010-11-18 US disclosed
US-20100240616-A1 NOVEL LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (NO) 2010-09-23 US disclosed